GLYCOBIA
Glycobia, Inc. develops platform technologies to enable glycoengineering, the intentional manipulation of protein-associated sugars to alter inherent properties of proteins for research, industrial and therapeutic applications. The company engages in developing glyco-engineered bacteria that are capable of attaching human or human-like sugars onto proteins. The company provides technology for efficient production of authentic human glycoproteins in microbial cells for manufacturing and engineering of therapeutic proteins. Glycobia, Inc. was incorporated in 2008 and is based in Ithaca, New York.
GLYCOBIA
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2008-01-01
Address:
Ithaca, New York, United States
Country:
United States
Website Url:
http://www.glycobia.com
Total Employee:
1+
Status:
Closed
Contact:
6072559166
Total Funding:
500 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft DNS Network Solutions